CA Patent

CA3137034A1 — Materials and methods for treating age-related macular degeneration

Assigned to University of California San Diego UCSD · Expires 2020-11-12 · 6y expired

What this patent protects

Described herein are materials and methods for the treatment of age-related macular degeneration by administering a combination of fenofibrate and an esterase inhibitor (e.g., kaempferol or telmisartan).

USPTO Abstract

Described herein are materials and methods for the treatment of age-related macular degeneration by administering a combination of fenofibrate and an esterase inhibitor (e.g., kaempferol or telmisartan).

Drugs covered by this patent

Patent Metadata

Patent number: CA3137034A1
Jurisdiction: CA
Classification: —
Expires: 2020-11-12
Drug substance claim: No
Drug product claim: No
Assignee: University of California San Diego UCSD
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.